SCHEMBL5459930

SCHEMBL5459930

CN(C)c1ccc(NC(=O)Nc2ccc(N3CCN(C(=O)O)CC3)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 2/20 0.56
MAPT P10636 9/20 0.52
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
SMN1; SMN2 Q16637 5/20 0.52
TP53 P04637 3/20 0.52
ESR2 Q92731 2/20 0.52
GAA P10253 2/20 0.52
RAB9A P51151 6/20 0.50
NPC1 O15118 5/20 0.50
NOX1 Q9Y5S8 3/20 0.50
L3MBTL1 Q9Y468 3/20 0.48
HTT P42858 2/20 0.48
LMNA P02545 2/20 0.48
PKM P14618 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
USP2 O75604 1/20 0.48
ALDH1A1 P00352 1/20 0.48
POLB P06746 1/20 0.48
HPGD P15428 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27859461 0.89 ALDH1A1 (0.57) NAMPTMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL5458134 0.83 NAMPT (0.61) NAMPTMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL5453579 0.82 MAPT (0.51) NAMPTMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL5460668 0.81 PANK3 (0.65) MAPTMEN1KMT2ASMN1; SMN2TP53
SCHEMBL5460936 0.81 MAPT (0.68) MAPTMEN1KMT2AGAARAB9A
SCHEMBL28152842 0.80 MEN1 (0.66) NAMPTMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL5462047 0.79 HTT (0.57) NAMPTMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL5473090 0.78 KMT2A (0.62) MAPTMEN1KMT2ASMN1; SMN2TP53
SCHEMBL5465649 0.78 KMT2A (0.60) NAMPTMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL5454329 0.78 KMT2A (0.57) NAMPTMAPTMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed
EP-1764360-A1 UREA DERIVATIVE Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 NAMPT 324/4885MAPT 758/4885MEN1 1828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.